Rare diseases
Investigational molecules
Locations
70 Avenue Tony Garnier, 69007 Lyon, France
MaaT PHARMA focuses on gastrointestinal acute graft-versus-host disease, with research directed toward treatment-resistant inflammatory complications affecting the digestive tract after allogeneic hematopoietic cell transplantation.
Its clinical activity includes patients with severe GI-aGvHD who have limited response to prior therapies, reflecting a strong therapeutic interest in post-transplant inflammatory disease.
Maat Pharma runs clinical trials in conditions such as Allogenic stem cell transplantation, Graft versus host disease, Acute graft versus host disease in intestine, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumFrance
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
